Analyst Recommendation Trends
Wall Street analyst consensus for ASTH over the last few months:
Latest ASTH News
Healthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers.
Why Astrana Health (ASTH) Shares Are Trading Lower Today
Shares of healthcare services company Astrana Health fell 5.5% in the afternoon session after the company disclosed a "material" cybersecurity incident and data breach at its subsidiary, Astrana Health Management.
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.004B Est
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.004 billion estimate.
Astrana Health Says Cybersecurity Incident Is Material After Unauthorized Data Access, Does Not Expect Material Financial Impact
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001083446/000110465926109813/asth-20260922x8k.htm
Sector Update: Healthcare Stocks Rise Thursday Afternoon
Healthcare stocks rose Thursday afternoon, with the NYSE Healthcare Index adding 0.5% and the State
Watching Astrana Health; Glass House Research Issues Report On Co Stating It Holds A Short Position
https://www.glasshouseresearch.com/uploads/8/9/6/9/89690703/asth_final_-_copy.pdf
Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know
A number of stocks fell in the morning session after bipartisan lawmakers introduced the Protecting Approved Care Act, legislation aimed at reforming prior authorization and payment rules in Medicare Advantage plans.
2 Cash-Producing Stocks with Competitive Advantages and 1 We Turn Down
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Oppenheimer Initiates Coverage On Astrana Health with Outperform Rating, Announces Price Target of $53
Oppenheimer analyst Michael Wiederhorn initiates coverage on Astrana Health (NASDAQ:ASTH) with a Outperform rating and announces Price Target of $53.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-15 | Vong John | -96 | $38.35 | $3,682 |
| 2026-09-05 | Sim Brandon | -7,163 | $38.47 | $275,561 |
| 2026-09-05 | Basho Chandan | -1,790 | $38.47 | $68,861 |
| 2026-08-31 | Kitayama Mitchell W | -8,500 | $37.09 | $315,265 |
| 2026-08-14 | Schmidt David | -20,000 | - | - |
| 2026-08-14 | Schmidt David | -20,000 | $38.59 | $771,800 |
| 2026-08-14 | Schmidt David | +20,000 | $5 | $100,000 |
| 2026-08-07 | Sobotka Glenn | -11,793 | - | - |
| 2026-06-10 | Schmidt David | +4,525 | - | - |
| 2026-06-10 | Mazdyasni Matthew | +4,525 | - | - |
| 2026-06-10 | Kitayama Mitchell W | +4,991 | - | - |
| 2026-06-10 | Dong Linda | +4,525 | - | - |
| 2026-06-10 | Dai, Weili | +4,525 | - | - |
| 2026-06-10 | Chiang John | +4,525 | - | - |
| 2026-05-16 | Basho Chandan | -8,155 | $38.26 | $312,010 |
| 2026-04-14 | Basho Chandan | -3,870 | $29.07 | $112,501 |
| 2026-04-06 | Lam Thomas S. | +41,667 | - | - |
| 2026-04-06 | Sim Kenneth T. | +100,000 | - | - |
| 2026-04-06 | Sim Brandon | +201,056 | - | - |
| 2026-04-02 | Basho Chandan | -2,092 | $25.05 | $52,405 |
| 2026-04-01 | Kumar Dinesh M. | -57,980 | $24.51 | $1,421,090 |
| 2026-04-01 | Kumar Dinesh M. | +35,300 | - | - |
| 2026-03-26 | Sobotka Glenn | -662 | $24.27 | $16,067 |
| 2026-03-05 | Lam Thomas S. | -9,266 | $25.07 | $232,299 |
| 2026-03-05 | Kumar Dinesh M. | -1,697 | $25.07 | $42,544 |
| 2026-03-05 | Basho Chandan | -1,240 | $25.07 | $31,087 |
| 2026-02-02 | Sim Brandon | -21,334 | - | - |
| 2026-02-02 | Sim Brandon | +21,334 | $23.24 | $495,802 |
| 2026-01-23 | Kumar Dinesh M. | -10,759 | $27.16 | $292,214 |
| 2026-01-13 | Schmidt David | -20,000 | - | - |
| 2026-01-13 | Schmidt David | -4,269 | $27.12 | $115,775 |
| 2026-01-13 | Schmidt David | +20,000 | $5.79 | $115,800 |
| 2026-01-01 | Kumar Dinesh M. | -5,102 | $24.81 | $126,581 |
| 2025-12-08 | Lam Thomas S. | -29,502 | - | - |
| 2025-12-08 | Lam Thomas S. | -25,866 | $22 | $569,052 |
| 2025-12-08 | Lam Thomas S. | +29,502 | $17.78 | $524,546 |
| 2025-11-10 | Sim Kenneth T. | -29,502 | - | - |
| 2025-11-10 | Sim Kenneth T. | +29,502 | $17.78 | $524,546 |
| 2025-11-10 | Mazdyasni Matthew | -20,000 | - | - |
| 2025-11-10 | Mazdyasni Matthew | +20,000 | $18.2 | $364,000 |
| 2025-11-07 | Kitayama Mitchell W | -12,000 | - | - |
| 2025-11-07 | Kitayama Mitchell W | +12,000 | $18.2 | $218,400 |
| 2025-11-03 | Marsh Linda | -20,000 | - | - |
| 2025-11-03 | Marsh Linda | -11,033 | $32.99 | $363,979 |
| 2025-11-03 | Marsh Linda | +20,000 | $18.2 | $364,000 |